17-N-Allylamino-17-demethoxygeldanamycin

Jump to: navigation, search
Template:Chembox E number
17-N-Allylamino-17-demethoxygeldanamycin
IUPAC name [(3S,5S,6R,7S,8E,10R,11S,12E,14E)-21-
(allylamino)-6-hydroxy-5,11-dimethoxy-3,
7,9,15-tetramethyl-16,20,22-trioxo-17-
azabicyclo[16.3.1]docosa-8,12,14,18,21-
pentaen-10-yl] carbamate
Identifiers
3D model (JSmol)
ECHA InfoCard Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value).
Properties
C31H43N3O8
Molar mass 585.689 g/mol
Except where noted otherwise, data are given for
materials in their standard state
(at 25 °C, 100 kPa)

Infobox disclaimer and references

WikiDoc Resources for 17-N-Allylamino-17-demethoxygeldanamycin

Articles

Most recent articles on 17-N-Allylamino-17-demethoxygeldanamycin

Most cited articles on 17-N-Allylamino-17-demethoxygeldanamycin

Review articles on 17-N-Allylamino-17-demethoxygeldanamycin

Articles on 17-N-Allylamino-17-demethoxygeldanamycin in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on 17-N-Allylamino-17-demethoxygeldanamycin

Images of 17-N-Allylamino-17-demethoxygeldanamycin

Photos of 17-N-Allylamino-17-demethoxygeldanamycin

Podcasts & MP3s on 17-N-Allylamino-17-demethoxygeldanamycin

Videos on 17-N-Allylamino-17-demethoxygeldanamycin

Evidence Based Medicine

Cochrane Collaboration on 17-N-Allylamino-17-demethoxygeldanamycin

Bandolier on 17-N-Allylamino-17-demethoxygeldanamycin

TRIP on 17-N-Allylamino-17-demethoxygeldanamycin

Clinical Trials

Ongoing Trials on 17-N-Allylamino-17-demethoxygeldanamycin at Clinical Trials.gov

Trial results on 17-N-Allylamino-17-demethoxygeldanamycin

Clinical Trials on 17-N-Allylamino-17-demethoxygeldanamycin at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on 17-N-Allylamino-17-demethoxygeldanamycin

NICE Guidance on 17-N-Allylamino-17-demethoxygeldanamycin

NHS PRODIGY Guidance

FDA on 17-N-Allylamino-17-demethoxygeldanamycin

CDC on 17-N-Allylamino-17-demethoxygeldanamycin

Books

Books on 17-N-Allylamino-17-demethoxygeldanamycin

News

17-N-Allylamino-17-demethoxygeldanamycin in the news

Be alerted to news on 17-N-Allylamino-17-demethoxygeldanamycin

News trends on 17-N-Allylamino-17-demethoxygeldanamycin

Commentary

Blogs on 17-N-Allylamino-17-demethoxygeldanamycin

Definitions

Definitions of 17-N-Allylamino-17-demethoxygeldanamycin

Patient Resources / Community

Patient resources on 17-N-Allylamino-17-demethoxygeldanamycin

Discussion groups on 17-N-Allylamino-17-demethoxygeldanamycin

Patient Handouts on 17-N-Allylamino-17-demethoxygeldanamycin

Directions to Hospitals Treating 17-N-Allylamino-17-demethoxygeldanamycin

Risk calculators and risk factors for 17-N-Allylamino-17-demethoxygeldanamycin

Healthcare Provider Resources

Symptoms of 17-N-Allylamino-17-demethoxygeldanamycin

Causes & Risk Factors for 17-N-Allylamino-17-demethoxygeldanamycin

Diagnostic studies for 17-N-Allylamino-17-demethoxygeldanamycin

Treatment of 17-N-Allylamino-17-demethoxygeldanamycin

Continuing Medical Education (CME)

CME Programs on 17-N-Allylamino-17-demethoxygeldanamycin

International

17-N-Allylamino-17-demethoxygeldanamycin en Espanol

17-N-Allylamino-17-demethoxygeldanamycin en Francais

Business

17-N-Allylamino-17-demethoxygeldanamycin in the Marketplace

Patents on 17-N-Allylamino-17-demethoxygeldanamycin

Experimental / Informatics

List of terms related to 17-N-Allylamino-17-demethoxygeldanamycin


17-N-Allylamino-17-demethoxygeldanamycin is a substance that is being studied in the treatment of cancer, specific young patients with certain types of leukemia or solid tumors, especially kidney tumors. As of June 2005, 17-N-allylamino-17-demethoxygeldanamycin is undergoing Phase 1 and Phase 2 clinical trials. It belongs to the family of drugs called antitumor antibiotics.

References


External links




Linked-in.jpg